Altice Europe N.V. Has Received a Request for Conversion of Preference Shares B

Regulatory News:

This is a press release by Altice Europe N.V. pursuant to the provisions of Section 5, paragraphs 4 and 5 and Section 6, paragraph 2 of the Dutch Decree on Public Takeover Bids (Besluit openbare biedingen Wft) to the extent applicable, in connection with the intended public offer by Next Private B.V. for all common shares A and common shares B in the capital of Altice Europe N.V. This announcement is for information purposes only and does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities. Any offer will be made only by means of an offer memorandum approved by the Dutch Authority for the Financial Markets (Autoriteit Financiële Markten). This announcement is not for release, publication or distribution, in whole or in part, in or into, directly or indirectly, the United States, Canada and Japan

Read More

Less than half of children received any therapy within 3 months — ScienceDaily

Children are struggling with mental health issues more now than perhaps ever before, though the treatment available — therapy, drugs, or both — differs widely from state to state.

Using a national database of insurance claims, Princeton University researchers investigated the type of treatment adolescents — most of whom were around the average age of 12 and suffering from anxiety or depression — receive after a first episode of mental illness.

Less than half of children received any therapy within three months, and 22.5% of children received only drug therapy, the researchers report in the Proceedings of the National Academy of Sciences (PNAS).

Of the children receiving drugs, 45% were prescribed strong, addictive drugs in the benzodiazepine class (like Valium or Xanax), tricyclic antidepressants, or drugs that were not FDA-approved for use in children as a first line of treatment.

The findings occur even in ZIP codes that are

Read More